Three women junior faculty named NCI K12 faculty scholars
Three Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine women junior faculty members have been named NCI K12 2024 faculty scholars.
The K12 Calabresi Clinical Oncology Research Career Development Program awards recipients with the resources needed for their careers in clinical and translational cancer research, according to a press release.

Photos courtesy of Sylvester Comprehensive Cancer Center at University of Miami Miller School of Medicine.
Marcella Kaddoura, MD, assistant professor of clinical medicine in the division of myeloma; Noa Holtzman, MD, assistant professor of clinical medicine in the division of transplantation and cellular therapy; and Gretel Terrero, MD, assistant professor of clinical medicine in the division of medical oncology — all at Sylvester Comprehensive Cancer Center — will begin an NCI-funded 2-year, intensive training program on Sept. 1.
They will be given dedicated time for research, mentorship, formal education and practical experience in creating hypothesis-driven research to improve cancer care delivery and patient outcomes, with a specific focus on patients receiving treatment at Sylvester Comprehensive Cancer Center, according to the release.
Kaddoura’s research will focus on computational oncology in multiple myeloma, with the goal of improving the use of existing therapies and discovering novel drug targets. Holtzman’s research will focus on improving outcomes for elderly patients with acute myeloid leukemia receiving hematopoietic stem cell transplantation. Terrero’s research will examine the unique tumor microenvironment and genomic characteristics of pancreatic adenocarcinoma.
“With the unwavering support of Sylvester Cancer Center’s director, Stephen D. Nimer, MD, and our dedicated leadership team, we are providing early-stage physician investigators with the time, support and resources to pursue innovative, impactful science, ultimately leading to better patient outcomes,” Alan Pollack, MD, PhD, K12 chair of radiation oncology at Sylvester Comprehensive Cancer Center and grant principal investigator, said in the release. “We are extremely proud to be among this select group, recognized for our commitment to training the next generation of leaders in clinical and translational cancer research. This year’s scholars, who represent three divisions in the department of medicine, impressed us with their passion and potential to advance oncology research.”